Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
Mayo Clinic
Hoffmann-La Roche
MultiVir, Inc.
Stanford University
University of Arizona
Novartis
National Cancer Institute (NCI)
Northside Hospital, Inc.
Pfizer